NCT03737695 2026-03-18
Clinical Information and Biospecimen Collection From Patients With Recurrent or Stage IV Breast Cancer
Mayo Clinic
Suspended
Clinical Trials
10 trialsNCT04955808 2026-03-18
Biospecimen Collection in Identifying Genetic Changes in Patients With Breast, Prostate, Colorectal, Liver, or Kidney Cancer or Multiple Myeloma Undergoing Surgery
National Cancer Institute (NCI)
Suspended
NCT05111561 2026-03-17
Testing the Combination of the Anticancer Drugs ZEN003694 and Binimetinib in Patients With Advanced/Metastatic or Unresectable Solid Tumors With RAS Alterations and Triple Negative Breast Cancer
National Cancer Institute (NCI)
Phase 1 Suspended
NCT05656131 2026-03-17
Fluzoparib in Combination With or Without Camrelizumab for Homologous Recombinant Deficiency (HRD) HER2 Negative Advanced Breast Cancer
Sun Yat-sen University
Phase 2 Suspended
NCT03077841 2026-03-05
Hypofractionated Partial Breast Irradiation in Treating Patients With Early Stage Breast Cancer
M.D. Anderson Cancer Center
Phase 2/3 Suspended
NCT07136493 2026-03-05
Circulating Tumor DNA Based Minimal Residual Disease Detection for Patients With Early-Stage Breast Cancer
City of Hope Medical Center
Phase NA Suspended
NCT06671912 2026-03-04
LoTam
Alliance for Clinical Trials in Oncology
Phase 3 Suspended
NCT02993068 2026-02-19
Stand up to Cancer: MAGENTA (Making Genetic Testing Accessible)
M.D. Anderson Cancer Center
Phase NA Suspended
NCT05000294 2026-02-18
Atezolizumab Plus Tivozanib in Immunologically Cold Tumor Types
University of Florida
Phase 1/2 Suspended
NCT05989828 2026-01-14
A2-ESO-1 TCR-Engineered T Cells for Relapsed/Refractory Advanced or Metastatic NY-ESO-1 Overexpression Positive Triple Negative Breast Cancer
University of Southern California
Phase 1 Suspended